This document is an essential companion to the third iteration of the National Academy of Clinical Biochemistry [NACB, 8 now the American Association for Clinical Chemistry (AACC) …
comprehensive review of the published evidence for management of a given condition according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
High-sensitivity cardiac troponin (hs-cTn) assays have been used clinically by thousands of physicians in many countries throughout the world since their clinical introduction 7 years …
XY Wang, F Zhang, C Zhang… - BioMed research …, 2020 - Wiley Online Library
The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom …
Background: Four strategies for very early rule-out of acute myocardial infarction using high- sensitivity cardiac troponin I (hs-cTnI) have been identified. It remains unclear which strategy …
Aims We aimed to evaluate the impact of age on the performance of the European Society of Cardiology (ESC) 0/1h-algorithms and to derive and externally validate alternative cut-offs …
KK Lee, AV Ferry, A Anand, FE Strachan… - Journal of the American …, 2019 - jacc.org
Background: Major disparities between women and men in the diagnosis, management, and outcomes of acute coronary syndrome are well recognized. Objectives: The aim of this study …
Background Diagnostic pathways for myocardial infarction rely on fixed troponin thresholds, which do not recognise that troponin varies by age, sex, and time within individuals. To …
C Huang, YR Neupane, XC Lim, R Shekhani… - Advances in clinical …, 2021 - Elsevier
Cardiovascular disease remains the leading cause of morbidity and mortality globally. Extracellular vesicles (EVs), a group of heterogeneous nanosized cell-derived vesicles …